IBI310 in Combination With Sintilimab in Patients With DNA Mismatch Repair Deficient (dMMR)/Microsatellite Instability High (MSI-H) Locally-advanced or Metastatic Colorectal Cancer

ABSTRACT: The main purpose of this study is to assess the efficacy and safety of IBI310 in combination with sintilimab in patients with Microsatellite Instability High (MSI-H) or Mismatch Repair Deficient (dMMR) locally advance or metastatic colorectal cancer.

DISEASE(S): Microsatellite Instability,Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2329228 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR